Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Intellia Therapeutics, Inc. | 69,527 | reported | 01 Mar 2026 | tx 8+49,051−10,747 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2026 | GRANT_AWARD | Intellia Therapeutics, Inc. | 17,250 | 0.00 USD | |
| 05 Jan 2026 | SALE | Intellia Therapeutics, Inc. | 2,989 | 9.21 USD | |
| 01 Oct 2025 | SALE | Intellia Therapeutics, Inc. | 1,871 | 17.38 USD | |
| 02 Jul 2025 | SALE | Intellia Therapeutics, Inc. | 2,503 | 9.95 USD | |
| 01 Mar 2025 | GRANT_AWARD | Intellia Therapeutics, Inc. | 14,000 | 0.00 USD | |
| 03 Jan 2025 | SALE | Intellia Therapeutics, Inc. | 1,372 | 12.18 USD | |
| 02 Oct 2024 | SALE | Intellia Therapeutics, Inc. | 2,012 | 19.01 USD | |
| 01 Jul 2024 | GRANT_AWARD | Intellia Therapeutics, Inc. | 17,801 | 0.00 USD |